B-cell acute lymphoblastic leukemia · 2 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
ECOG-ACRIN E1910 protocol with blinatumomab Partial | — | — | — | — | — | — | — | 1 |
ECOG-ACRIN E1910 protocol without blinatumomab Partial | — | — | — | — | — | — | — | 1 |
2 of 2 regimens shown